The DOI matches its Crossref record; 65 of the 65 references it cites were found in a registry or an index.
Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci
Open accessAbstract
Genome-wide association studies (GWAS) and fine-mapping efforts to date have identified more than 100 prostate cancer (PrCa)-susceptibility loci. We meta-analyzed genotype data from a custom high-density array of 46,939 PrCa cases and 27,910 controls of European ancestry with previously genotyped data of 32,255 PrCa cases and 33,202 controls of European ancestry. Our analysis identified 62 novel loci associated (P < 5.0 × 10-8) with PrCa and one locus significantly associated with early-onset PrCa (≤55 years). Our findings include missense variants rs1800057 (odds ratio (OR) = 1.16; P = 8.2 × 10-9; G>C, p.Pro1054Arg) in ATM and rs2066827 (OR = 1.06; P = 2.3 × 10-9; T>G, p.Val109Gly) in CDKN1B. The combination of all loci captured 28.4% of the PrCa familial relative risk, and a polygenic risk score conferred an elevated PrCa risk for men in the ninetieth to ninety-ninth percentiles (relative risk = 2.69; 95% confidence interval (CI): 2.55-2.82) and first percentile (relative risk = 5.71; 95% CI: 5.04-6.48) risk stratum compared with the population average. These findings improve risk prediction, enhance fine-mapping, and provide insight into the underlying biology of PrCa 1.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“For example, polygenic risk scores alone already predict breast cancer, prostate cancer, and type 1 diabetes risk in European descent patients more accurately than current clinical models2–4.”
From Clinical use of current polygenic risk scores may exacerbate health disparities (2019) · cites this paper as [3]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Subramanian, A., Tamayo, P., Mootha, V. K., Mukherjee, S., Ebert, B. L., Gillette, M. A., Paulovich, A., Pomeroy, S. L., Golub, T. R., Lander, E. S., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0506580102 · Cited by 53,625
Cytoscape: A software Environment for integrated models of biomolecular interaction networks
Shannon, P., Markiel, A., Ozier, O., Baliga, N. S., Wang, J. T., Ramage, D., Amin, N., Schwikowski, B., & Ideker, T. (2003) · Genome Research · doi:10.1101/gr.1239303 · Cited by 51,888
Gene Ontology: tool for the unification of biology
Ashburner, M., Ball, C. A., Blake, J. A., Botstein, D., Butler, H., Cherry, J. M., Davis, A. P., Dolinski, K., Dwight, S. S., Eppig, J. T., et al. (2000) · Nature Genetics · doi:10.1038/75556 · Cited by 43,206
Siegel, R. L., Miller, K. D., & Jemal, A. (2016) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21332 · Cited by 16,003
ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data
Wang, K., Li, M., & Hakonarson, H. H. (2010) · Nucleic Acids Research · doi:10.1093/nar/gkq603 · Cited by 14,724
METAL: fast and efficient meta-analysis of genomewide association scans
Willer, C. J., Li, Y., & Abecasis, G. R. (2010) · Bioinformatics · doi:10.1093/bioinformatics/btq340 · Cited by 5,205
Howie, B. N., Donnelly, P., & Marchini, J. (2009) · PLoS Genetics · doi:10.1371/journal.pgen.1000529 · Cited by 3,928
PANTHER: A Library of Protein Families and Subfamilies Indexed by FunctionPreprint
Thomas, P. D., Campbell, M. J., Kejariwal, A., Mi, H., Karlak, B., Daverman, R., Diemer, K., Muruganujan, A., & Narechania, A. (2003) · Genome Research · doi:10.1101/gr.772403 · Cited by 2,978
Enrichment Map: A Network-Based Method for Gene-Set Enrichment Visualization and Interpretation
Merico, D., Isserlin, R., Stueker, O., Emili, A., & Bader, G. D. (2010) · PLoS ONE · doi:10.1371/journal.pone.0013984 · Cited by 2,235
DNA-Repair Defects and Olaparib in Metastatic Prostate Cancer
Mateo, J., Carreira, S., Sandhu, S., Miranda, S., Mossop, H., Perez-Lopez, R., Nava Rodrigues, D., Robinson, D., Omlin, A., Tunariu, N., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1506859 · Cited by 2,185
Cited by
Sorted by citations
Items 501–600 of 918
Genetic predisposition to mosaic Y chromosome loss in blood.
Thompson, D. J., Genovese, G., Halvardson, J., Ulirsch, J. C., Wright, D. J., Terao, C. C., Davidsson, O. B., Day, F. R., Sulem, P., Jiang, Y., et al. (2019) · Apollo (University of Cambridge) · doi:10.17863/cam.42407 · Cited by 5
Self-citationZhou, Z., Xu, J., Zhao, Y., & Niu, Y. (2024) · Food & Function · doi:10.1039/d4fo03859b · Cited by 5
Self-citationHe, J., Perera, D., Wen, W., Ping, J., Li, Q., Lyu, L., Chen, Z., Shu, X., Long, J., Cai, Q., et al. (2024) · Nucleic Acids Research · doi:10.1093/nar/gkae1035 · Cited by 8
Self-citationFeng, C., Li, H., Zhang, C., Zhou, Y., Zhang, H., Zheng, P., Zhao, S., Wang, L., & Yang, J. (2025) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2024.1406055 · Cited by 7
Self-citationSun, Y., Zhu, J., Zhong, H., Zhang, Z., Wang, F., Nakamura, A., Liu, Y., Liu, J., Yu, J., Zeng, G., et al. (2025) · The Prostate · doi:10.1002/pros.24859 · Cited by 5
“These 51 likely causal genes for PCa risk were also reported in previous TWAS or splicing TWAS studies [7 – 14] or located at known loci for PCa [31, 35 – 37].”
Germline Testing for Prostate Cancer Prognosis
Helfand, B. T., & Xu, J. (2021) · Urologic Clinics of North America · doi:10.1016/j.ucl.2021.04.003 · Cited by 5
Self-citationSystematic fine-mapping and functional studies of prostate cancer risk variants
Qian, Y., Wang, J., Wang, B., Wang, W., Li, P., Zhao, Z., Jiang, Y., Ren, H., Huang, D., Yang, Y., et al. (2023) · iScience · doi:10.1016/j.isci.2023.106497 · Cited by 6
Zhan, Y., Ruan, X., Wang, P., Huang, D., Huang, J., Huang, J., Chun, T. T. S., Ho, B., Ng, A. T., Tsu, J. H., et al. (2023) · Biology · doi:10.3390/biology12050673 · Cited by 5
“61,106 controls) [16], whereas those for East Asian ancestry were from the Chinese Consortium for Prostate Cancer Genetics (ChinaPCa) (3343 and 3315) [13,14].”
BackgroundIdentifying Cancer Type-Specific Transcriptional Programs through Network Analysis
Kurup, J. T., Kim, S., & Kidder, B. L. (2023) · Cancers · doi:10.3390/cancers15164167 · Cited by 5
Mulugeta, A., Lumsden, A. L., Madakkatel, I., Stacey, D., Lee, S., Maenpaa, J. U., Oehler, M. K., & Hyppönen, E. (2024) · Cancer Medicine · doi:10.1002/cam4.7051 · Cited by 4
“Importantly, we confirmed previous associations of the TERT variant with uterine 293 leiomyoma 53 and total protein levels in women (51), as well as with prostate cancer in men.(54) Our 294 findings highlight the value of using PheWAS for validating previous GWAS findings and identifying 295 potential novel variants f…”
Hung, S.-C., Chang, L.-W., Hsiao, T., Wei, C., Wang, S., Li, J., & Chen, I. (2024) · Scientific Reports · doi:10.1038/s41598-024-71544-7 · Cited by 5
“For instance, men in the ninetieth to ninety-ninth percentiles of PRS would have a 2.69-fold increased risk of developing prostate cancer compared to the population average, and this risk would further increase to 5.71-fold for men in the first percentile 8 .”
BackgroundInfluentialYarmolinsky, J., Lee, M. A., Lau, E., Moratalla-Navarro, F., Vincent, E. E., Li‐Gao, R., Rensen, P. C. N., van Dijk, K. W., Tsilidis, K. K., Sangphukieo, A., et al. (2025) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djaf137 · Cited by 5
“32-36 For genetic instrument validation analyses, summary genetic association data on circulating LDL cholesterol, HDL cholesterol, and triglycerides were obtained from analyses of � 1.3 million participants in the Global Lipids Genetics Consortium (GLGC) analysis.”
InfluentialCross-population analysis for functional characterization of type II diabetes variants
Elmansy, D., & Koyutürk, M. (2019) · BMC Bioinformatics · doi:10.1186/s12859-019-2835-0 · Cited by 6
Biobanks in oncology: global experience and Russian reality
Каприн, А. Д., Иванов, С. А., Petrov, V. A., Dukhova, N. N., Dvinskikh, N. Y., Falaleeva, N. A., & Гривцова, Л. Ю. (2020) · Journal of Modern Oncology · doi:10.26442/18151434.2020.2.200103 · Cited by 5
Sathyanarayanan, A., Tanha, H. M., Mehta, D., & Nyholt, D. R. (2022) · Communications Biology · doi:10.1038/s42003-022-03540-4 · Cited by 5
Pärna, K., Nolte, I. M., Snieder, H., Fischer, K., Marnetto, D., & Pagani, L. (2022) · Frontiers in Genetics · doi:10.3389/fgene.2022.899523 · Cited by 5
Kazmi, N., Валерьевна, В. Е., Рашатовна, Х. Г., Lewis, S. J., & Plotnikov, D. (2023) · Cancer Causes & Control · doi:10.1007/s10552-023-01712-z · Cited by 5
“1 3 for overall prostate cancer in 79,148 cases and 61,106 controls [28].”
BackgroundPathway Analysis of Genes Identified through Post-GWAS to Underpin Prostate Cancer Aetiology
Farashi, S., Kryza, T., & Batra, J. (2020) · Genes · doi:10.3390/genes11050526 · Cited by 5
“using GWAS risk loci, including some functional variants, identified the PD-1 signalling as the most significant pathway [45] in addition to the antigen processing, presentation and IFNG mediated signalling pathways [46].”
MethodSelf-citationGenetics of prostate cancer and its utility in treatment and screening
Benafif, S., Raghallaigh, H. N., McHugh, J. K., & Eeles, R. A. (2021) · Advances in genetics · doi:10.1016/bs.adgen.2021.08.006 · Cited by 6
Self-citationDerandomizing KnockoffsPreprint
Ren, Z., Wei, Y., & Candès, E. J. (2020) · arXiv (Cornell University) · doi:10.48550/arxiv.2012.02717 · Cited by 5
“We take the meta-analysis conducted by Schumacher et al. (2018) as the early-stage study, and apply derandomized knockoffs on a dataset from the U.K. Biobank for a confirmatory analysis.”
MethodResultArchaic adaptive introgression in modern human reproductive genes
Kendall, C., Nooranikhojasteh, A., Parra, E. J., Schillaci, M. A., & Viola, B. (2025) · Communications Biology · doi:10.1038/s42003-025-08682-9 · Cited by 6
“These genes, ENSG00000225205 , ENSG00000226963 , ITGA6 , and ITGA6-AS1 , have archaic alleles that reduce the risk of prostate cancer (Supplementary Data 4) reported in large GWAS cohorts from Asia and Europe 91,94,96,97 .”
Prostate Cancer: genetics in practice now and in the future
McHugh, J. K., Bancroft, E. K., Kote‐Jarai, Z., & Eeles, R. A. (2025) · Hereditary Cancer in Clinical Practice · doi:10.1186/s13053-025-00310-1 · Cited by 4
“These PrCa risk-associated SNPs may confer lower risk individually but multiplicatively can add to up to at least 2.7-fold increased risk of PrCa for those in the top decile of PRS [11].”
InfluentialSelf-citationLi, Q., Song, Q., Chen, Z., Choi, J.-Y., Moreno, V. R., Ping, J., Wen, W., Li, C., Shu, X., Yan, J., et al. (2025) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2025.11.008 · Cited by 4
Self-citationJiang, X., O'Neill, A., Smith, K. R., Lai, Z., Carss, K., Wang, Q., & Petrovski, S. (2022) · Genes Chromosomes and Cancer · doi:10.1002/gcc.23042 · Cited by 4
“A previous meta-analyzed GWAS identified the association between rs1800057 and uterine fibroid in women of European ancestry.26 Schumacher et al.27 previously reported that rs1800057-G was associated with increased risk of prostate cancer in a meta-analysis of over 140 000 European males (p: 8.1 10 9, OR: 1.16 [95% CI…”
BackgroundInfluentialThe Role of Family History and Germline Genetics in Prostate Cancer Disease Profile and Screening
Raghallaigh, H. N., & Bott, S. (2022) · Exon Publications eBooks · doi:10.36255/exon-publications-urologic-cancers-prostate-cancer-family-history-genetics · Cited by 4
Yoon, B. W., Shin, H., & Seo, J. H. (2022) · Genes · doi:10.3390/genes13112039 · Cited by 4
Sun, Y., Bae, Y. E., Zhu, J., Zhang, Z., Zhong, H., Cheng, C.-M., Deng, Y., Wu, C., & Wu, L. (2023) · OMICS A Journal of Integrative Biology · doi:10.1089/omi.2023.0065 · Cited by 4
Kong, X., Yu, J., Zhu, Z., Wang, C., Zhang, R., Qi, J., Wang, Y., Wang, X., Pan, S., Liu, L., et al. (2023) · Molecular Genetics and Genomics · doi:10.1007/s00438-023-02057-7 · Cited by 4
“The GWAS data for prostate cancer were derived from a meta-analysis that involved 79,148 cases and 61,106 controls (Schumacher et al. 2018).”
MethodGenetic estimation of correlations between circulating glutamine and cancer.
Zhang, K., & Liang, H. (2023) · PubMed Central · Cited by 4
A comprehensive analysis of clinical and polygenic germline influences on somatic mutational burden
Taraszka, K., Groha, S., King, D., Tell, R. W., White, K. P., Ziv, E., Zaitlen, N., & Gusev, A. (2024) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2023.12.010 · Cited by 4
Mainstream Model of Genetic Testing for Prostate Cancer at a Large Tertiary Cancer Centre
Wang, X., Waldman, L., Silberman, Y., Wang, M. L., Tackey, C., Hanna, L., Vesprini, D., Emmenegger, U., Eisen, A. F., & Smoragiewicz, M. (2024) · Clinical Genitourinary Cancer · doi:10.1016/j.clgc.2024.02.003 · Cited by 4
Xu, J., Chen, R., Yang, Y., Xu, S., & Yao, L. (2024) · Aging · doi:10.18632/aging.205934 · Cited by 4
Self-citationTyrer, J., Peng, P., DeVries, A., Gayther, S., Jones, M. R., & Pharoah, P. (2024) · BMC Genomics · doi:10.1186/s12864-024-10706-3 · Cited by 3
Self-citationPan, R., Liu, J., Xiao, M., Sun, C., Zhu, J., Wan, L., & Xue, B. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2024.1443330 · Cited by 4
Yu, J., Cho, E., Choi, J., Lim, J. E., Lee, J., Kang, M., Sung, H. H., Jeong, B. C., Seo, S. I., Jeon, S. S., et al. (2021) · Korean journal of urology · doi:10.4111/icu.20200406 · Cited by 4
Self-citationPolygenic risk score for tumor aggressiveness and early-onset prostate cancer in Asians
Song, S. H., Kim, E., Jung, Y. J., Kim, H., Park, M. S., Kim, J. K., Lee, H., Oh, J. J., Lee, S., Hong, S. K., et al. (2023) · Scientific Reports · doi:10.1038/s41598-022-17515-2 · Cited by 4
Self-citationVasectomy and risk of prostate cancer: A Mendelian randomization study and confounder analysis
Di, H., & Wen, Y. (2023) · The Prostate · doi:10.1002/pros.24646 · Cited by 4
“15 Recently, large ‐ scale genome ‐ wide association studies (GWASs) of vasectomy, 17 ever had PSA test, 18 time since last PSA test, 19 body mass index (BMI), 20 and PCa 21 have identified genetic loci associated with each of these factors, with data stratified by gender available as well.”
BackgroundA Mendelian randomization study between metabolic syndrome and its components with prostate cancer
Xia, L., Yu, X., Wang, L., Yang, L., Bao, E., Wang, B., & Zhu, P.-Y. (2024) · Scientific Reports · doi:10.1038/s41598-024-65310-y · Cited by 4
“Data on genetic variants in PCa was acquired from the PRACTICAL consortium, which conducted a large study including 79,148 cases and 61,106 controls of European ancestry, ultimately including 20,346,368 SNPs 23 .”
MethodShao, M., Tian, M., Chen, K., Jiang, H., Zhang, S., Li, Z., Shen, Y. F., Chen, F., Shen, B., Cao, C., et al. (2024) · Advanced Science · doi:10.1002/advs.202400815 · Cited by 3
Lalagkas, P. N., & Melamed, R. (2024) · Human Genomics · doi:10.1186/s40246-024-00688-4 · Cited by 5
Orsi, L., Margaritte‐Jeannin, P., Andrianjafimasy, M. V., Dumas, O., Mohamdi, H., Bouzigon, E., Démenais, F., Matran, R., Zerimech, F., Nadif, R., et al. (2022) · Antioxidants · doi:10.3390/antiox11050802 · Cited by 4
Joslin, S. E. K., Durbin-Johnson, B. P., Britton, M., Settles, M. L., Korf, I. F., & Lemay, D. G. (2020) · Frontiers in Genetics · doi:10.3389/fgene.2020.558762 · Cited by 4
Hollis, B., Day, F. R., Busch, A. S., Thompson, D. J., Soares, A. G., Timmers, P. R. H. J., Kwong, A. S. F., Easton, D. F., Joshi, P. K., Timpson, N. J., et al. (2018) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/483933 · Cited by 4
Self-citationSandu, M., Beynon, R. A., Richmond, R. C., Ferreira, D. L. S., Hackshaw‐McGeagh, L., Smith, G. D., Metcalfe, C. D., Lane, J. A., & Martin, R. W. (2019) · Preprints.org · doi:10.20944/preprints201910.0276.v1 · Cited by 4
“Table 1: The effects of lycopene and green tea dietary interventions on NMR measured circulating metabolites in ProDiet (Step 1 Results) and the effects of metabolites on prostate cancer risk(PRACTICAL) (step 2)(9, 12, 14).”
BackgroundSelf-citationHuynh‐Le, M., Karunamuni, R. A., Fan, C. C., Thompson, W. K., Muir, K. R., Lophatananon, A., Tye, K. E., Wolk, A., Håkansson, N., Mills, I. G., et al. (2020) · medRxiv · doi:10.1101/2020.09.16.20192666 · Cited by 4
Self-citationLocus- and Gene-Level Insights into the Inverse Association Between Alzheimer’s Disease and Cancer
Debnath, D., Housini, M., Sariya, S., Phillips, N. R., Pathak, G. A., & Barber, R. C. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27062900 · Cited by 2
Causal roles of dietary structure and types on prostate cancer risk: A mendelian randomization study
Li, C., Jing, Z., Guo, Q., Zheng, Z., Zhao, X., Yuan, W., Xi, Y., & Wang, J. (2024) · BMC Cancer · doi:10.1186/s12885-024-13252-z · Cited by 3
“After removing duplicate individuals the final analysis summed data from OncoAr-ray analysis and a high-density SNP combination of seven prior PCa GWAS or European ancestry, including 79,194 individuals with PCa and 61,112 healthy individuals [16].”
Chen, J., Epstein, M. P., Schildkraut, J. M., & Kar, S. (2025) · Genes · doi:10.3390/genes16050575 · Cited by 4
“GWAS summary statistics were obtained from a meta-analysis of 79,148 cases and 61,106 controls for prostate cancer risk [10]; and from a meta-analysis involving 12,906 cases and 108,979 controls for endometrial cancer risk [11].”
Germline–Somatic Liaison Dictates Cancer Subtypes via de novo Steroid Biosynthesis
Gasperini, P., Alaimo, A., Stringa, B., Chung, Y., Ciani, Y., Lorenzin, F., Fracassi, G., Zekri, Y., Orlando, F., Quaini, O., et al. (2025) · Cancer Discovery · doi:10.1158/2159-8290.cd-24-1904 · Cited by 3
“Whereas age, family history, and ancestry have been re-ported as the prominent prostate cancer risk factors by epidemiologic studies, the genetic component remains the leading player of prostate cancer etiology, as evidenced by familial linkage studies, twin-based studies, and GWAS efforts (3, 57).”
Yarmolinsky, J., Lau, E., Koskeridis, F., Gunter, M. J., Wang, D. Y. Q., Dehghan, A., & Tzoulaki, I. (2025) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.125.322433 · Cited by 3
The role of genetic testing in prostate cancer screening, diagnosis, and treatment
de la Calle, C. M., Bhanji, Y., Pavlovich, C. P., & Isaacs, W. B. (2022) · Current Opinion in Oncology · doi:10.1097/cco.0000000000000823 · Cited by 5
Guan, Z., Begg, C. B., & Shen, R. (2023) · Cancer Research Communications · doi:10.1158/2767-9764.crc-22-0355 · Cited by 4
Amini, A. E., & Salari, K. (2024) · JCO Precision Oncology · doi:10.1200/po.23.00560 · Cited by 3
Jin, X. Y., Wu, M., Dong, S., Liu, H., & Ma, H. (2024) · Frontiers in Nutrition · doi:10.3389/fnut.2024.1347724 · Cited by 4
Liu, S., Zhu, J., Green, D., Zhong, H., Long, Q., Wu, C., Wang, L., Deng, Y., & Wu, L. (2024) · Molecular Carcinogenesis · doi:10.1002/mc.23828 · Cited by 3
“To date, multiple studies have reported DNAm biomarkers associated with PCa risk [11 – 15].”
Zhao, J. V., & Zhang, J. (2024) · Nutrients · doi:10.3390/nu16213674 · Cited by 3
“We acquired genetic associations for prostate cancer from the PRACTICAL consortium (Prostate Cancer Association Group to Investigate Cancer-Associated Alterations in the Genome), which included 79,148 cases and 61,106 controls, adjusting for principal components and relevant study covariates [28].”
MethodChernoff, M., Demanelis, K., Gillard, M., Delgado, D., Gleason, K. J., Oliva, M., Chen, L., Williams, A. J., Szmulewitz, R. Z., Griend, D. J. V., et al. (2024) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-24-0288 · Cited by 3
Characterizing substructure via mixture modeling in large-scale genetic summary statistics
Stoneman, H. R., Price, A., Trout, N. S., Lamont, R., Tifour, S., Pozdeyev, N. V., Anderson, H. D., Aquilante, C. L., Arbogast, K., Arehart, C. H., et al. (2025) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2024.12.007 · Cited by 3
“45,46 We derived the case AFs from the reported odds ratios and control AFs (Note The American Journal of Human Genetics 112 , 235–253, February 6, 2025 239 S4).”
The Spanish Polygenic Score reference distribution: a resource for personalized medicine
Carmona, R., Roldán, G., Fernández-Rueda, J. L., Navarro, A., Peña-Chilet, M., CSVS Crowdsourcing Group, Alonso, A., Salgado-Garrido, J., Pasalodos-Sanchez, S., Aquino, V., et al. (2025) · European Journal of Human Genetics · doi:10.1038/s41431-025-01850-9 · Cited by 3
“PGSs have the potential to enhance the prediction of disease risks like breast cancer [10], prostate cancer [11], and type 1 diabetes [12], particularly in individuals of European descent, and may offer improvements over some current clinical models [13].”
Wei, C., He, J., Li, Y., Luo, Y., Song, L., Han, K., Zhang, J., Su, S., & Wang, D. (2025) · Discover Oncology · doi:10.1007/s12672-025-02584-2 · Cited by 3
“Participants from PRACTICAL included a total of 79,148 cases and 61,106 controls [30].”
Chalitsios, C. V., Pagkalidou, E., Papagiannopoulos, C. K., Markozannes, G., Bouras, E., Watts, E. L., Richmond, R. C., & Tsilidis, K. K. (2025) · Cancer Epidemiology · doi:10.1016/j.canep.2025.102877 · Cited by 3
Efficient candidate drug target discovery through proteogenomics in a Scottish cohort
Kuliesius, J., Timmers, P. R. H. J., Navarro, P., Klarić, L., & Wilson, J. F. (2025) · Communications Biology · doi:10.1038/s42003-025-08738-w · Cited by 3
“…the cis -associated rs78760579 (effect allele G, effect size = − 0.80, p = 3.7 × 10 − 8 ) is in LD (Pearson r 2 > 0.8) with a recently reported variant, rs878987 ( p = 2.7 × 10 − 6 in this study), detected as the lead variant in large case-control prostate cancer GWAS 22,23 ( p = 4.8 × 10 − 8 ).”
InfluentialGermline genetics in localized prostate cancer
Ryan, S. T., Nguyen, V., Bree, K. K., Holst, D. D., & Kader, A. K. (2019) · Current Opinion in Urology · doi:10.1097/mou.0000000000000648 · Cited by 3
Gene‒Prostate-Specific-Antigen-Guided Personalized Screening for Prostate Cancer
Yang, T.-K., Chuang, P.-C., Yen, A. M., Chen, H.-H., & Chen, S. L. (2019) · Genes · doi:10.3390/genes10090641 · Cited by 3
“Over the past three decades, there are numerous studies on genetic variants that have identified a constellation of SNPs accounting for the risk of being susceptible to PrCa [7].”
BackgroundCancer Predisposition Genes in Cancer-Free Families
Zheng, G., Catalano, C., Bandapalli, O. R., Paramasivam, N., Chattopadhyay, S., Schlesner, M., Sijmons, R. H., Hemminki, A., Dymerska, D., Lubiński, J., et al. (2020) · Cancers · doi:10.3390/cancers12102770 · Cited by 3
“Five large recently published meta-analyses were used to collect single nucleotide polymorphisms (SNPs) predicted by genome-wide association studies (GWASs) to be associated with the risk of breast [8,15], colorectal [8,14], and prostate cancers [16] at the genome-wide significance level.”
Santiago, F., Silvestre, R. T., Otero, U. B., Tabalipa, M. M., Ribeiro-Carvalho, M. D. M., Scherrer, L. R., Al‐Rikabi, A., Liehr, T., Alves, G., & Ornellas, M. H. (2021) · International Archives of Occupational and Environmental Health · doi:10.1007/s00420-021-01652-8 · Cited by 3
Estimating genetic correlation jointly using individual-level and summary-level GWAS data
Zhang, Y., Jiang, W., Shen, J., Cheng, Y., Ye, Y., Lu, Q., & Zhao, H. (2026) · Nature Communications · doi:10.1038/s41467-026-76693-z · Cited by 3
“Due to the unstable estimates for heritability, the transethnic genetic correlation estimates of Popcorn for prostate cancer (PC) 29 were unavailable.”
rs77283072 influences breast cancer susceptibility by regulating CDKN2A expression
He, G.-H., Liu, S.-D., Shi, X., Chen, Y., Su, L., Shi, Q.-N., & Sun, C. (2023) · Oncology Letters · doi:10.3892/ol.2023.13662 · Cited by 3
Genetic variants of glucose metabolism and exposure to smoking in African American breast cancer
Jung, S. Y., Papp, J. C., Sobel, E. M., Pellegrini, M. A., & Yu, H. (2023) · Endocrine Related Cancer · doi:10.1530/erc-22-0184 · Cited by 3
Cannon‐Albright, L., Stevens, J., Facelli, J. C., Teerlink, C. C., Allen‐Brady, K., & Agarwal, N. (2023) · Cancers · doi:10.3390/cancers15072085 · Cited by 3
“, [7]), few rare variants in moderate- to high-penetrance genes have been identified, and they explain little of familial prostate cancer [8,9].”
BackgroundSelf-citationMa, C., Wang, X., Dai, J. Y., Turman, C., Kraft, P., Stopsack, K. H., Loda, M. F., Pettersson, A., Mucci, L. A., Stanford, J. L., et al. (2023) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-23-0275 · Cited by 3
Self-citationTextural Analysis Supports Prostate MR Diagnosis in PIRADS Protocol
Gibała, S., Obuchowicz, R., Lasek, J., Piórkowski, A., & Nurzyǹska, K. (2023) · Applied Sciences · doi:10.3390/app13179871 · Cited by 3
Cannon‐Albright, L., Stevens, J., Teerlink, C. C., Facelli, J. C., Allen‐Brady, K., & Welm, A. L. (2023) · Cancers · doi:10.3390/cancers15245851 · Cited by 3
Self-citationCornish, N., Haycock, P., Brenner, H., Figueiredo, J. C., Galesloot, T. E., Grant, R. C., Johansson, M., Mariosa, D., McKay, J., Pai, R. K., et al. (2023) · International Journal of Epidemiology · doi:10.1093/ije/dyad170 · Cited by 3
Self-citationZhang, X., Yu, X., Xu, S.-J., Shi, X., Chen, Y., Shi, Q., & Sun, C. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e27802 · Cited by 3
“…surrounding region is competitively occupied by other proteins. rs2736098 has been suggested to be significantly associated with carcinogenesis in multiple tissues besides breast, including lung, basal cell, bladder, prostate, cervix, liver, pancreas, colon, ovary, B cell, head and neck [29 – 41].”
BackgroundChen, P., Wang, Y., Xiong, Z., Luo, T., Lai, Y., Zhong, H., Peng, S., Zhuang, R., Li, K., & Huang, H. W. (2024) · Cancer Pathogenesis and Therapy · doi:10.1016/j.cpt.2024.03.002 · Cited by 3
Rumpf, F., Plym, A., Vaselkiv, J. B., Penney, K. L., Preston, M. A., Kibel, A. S., Mucci, L. A., & Salari, K. (2024) · The Journal of Urology · doi:10.1097/ju.0000000000003927 · Cited by 3
“16,17 17-19 While not prognostic, a high PRS increases lifetime risk of high-grade and lethal prostate cancer.”
BackgroundSelf-citationAbar, L., Zuber, V., Otto, G., Tzoulaki, I., & Dehghan, A. (2024) · NAR Genomics and Bioinformatics · doi:10.1093/nargab/lqae046 · Cited by 3
“…two-sample MR analysis for traits of a number of complex disorders, including CAD ( 28 ), late-onset AD ( 29 ), breast cancer ( 30 ) and prostate cancer ( 31 ), using genetic estimate associations reported in the largest GWAS summary statistics in independent populations ( Supplementary Table S1 ).”
MethodHsieh, A., Luo, Y., Bao, B., & Chou, T. (2024) · BMC Urology · doi:10.1186/s12894-024-01524-6 · Cited by 3
Weng, W., Hsieh, Y., Lin, C., Liu, Y., Su, S., Wang, S., & Yang, S. (2024) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.70041 · Cited by 3
“26 Although extensive genome-wide association studies have reported numerous common SNPs of modest effects on PCa risks, 27–30 the genetic mechanism behind such susceptibility remains still largely elusive.”
BackgroundQiu, Z., Fan, J., He, J., Huang, X., Yang, Z., Sheng, Q., & Jin, L. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e39732 · Cited by 3
Prostate cancer screening: a new way forward or another false start?
Albertsen, P. C. (2021) · Nature Reviews Urology · doi:10.1038/s41585-021-00513-w · Cited by 3
Zhang, W., Nicholson, T., & Zhang, K. (2021) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-21-0406 · Cited by 3
Pleiotropy in eye disease and related traits
Gao, X. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-816222-4.00020-4 · Cited by 3
Biomarker Evaluation and Clinical Development
Vickers, A. J., & Assel, M. J. (2020) · Société Internationale d’Urologie Journal · doi:10.48083/zcjs3811 · Cited by 3
“Well-known studies such as the PRACTICAL collaboration have developed polygenic risk scores for the endpoint of incident prostate cancer [11].”
BackgroundGenetically Informed Prostate Cancer Screening
Arcot, R., Morgan, T. M., & Polascik, T. J. (2021) · Urologic Clinics of North America · doi:10.1016/j.ucl.2021.04.001 · Cited by 3
Papadimitriou, N., Kazmi, N., Dimou, N. L., Tsilidis, K. K., Martin, R. M., Lewis, S. J., Lynch, B. M., Hoffmeister, M., Kweon, S., Li, L., et al. (2023) · Cancer Medicine · doi:10.1002/cam4.6732 · Cited by 2
“19 The same consortia also conducted a GWAS of aggressive prostate cancer involving 15,167 cases and 58,308 controls, in which cancer cases were defined as aggressive based on the following characteristics: Gleason score ≥ 8, Prostate-Specific Antigen > 100 ng/ mL, metastatic disease (M1) or death…”
BackgroundSelf-citationGenomic underpinnings of lifespan allow prediction and reveal basis in modern risksPreprint
Timmers, P. R. H. J., Mounier, N., Läll, K., Fischer, K., Zheng, N., Feng, X., Bretherick, A. D., Clark, D. W., Shen, X., Esko, T., et al. (2018) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/363036 · Cited by 3
“However, 54 although genome-wide association studies (GWAS) of mortality risk factors (such as 55 cardiovascular traits and cancer) have had remarkable success (17-21), GWAS of longevity 56 has proved more challenging, with only two robustly replicated, genome-wide significant 57 associations (near APOE, FOXO3) having…”
BackgroundBurrows, K., Kazmi, N., Haycock, P., Tsilidis, K. K., GECCO, C. A. C., Martin, R. M., & Lewis, S. J. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/762138 · Cited by 2
Self-citationAmariuta, T., Ishigaki, K., Sugishita, H., Ohta, T., Matsuda, K., Murakami, Y., Price, A. L., Kawakami, E., Terao, C. C., & Raychaudhuri, S. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.02.21.959510 · Cited by 3
Precision Breast Cancer Screening with a Polygenic Risk ScorePreprint
Tasa, T., Puustusmaa, M., Tõnisson, N., Kolk, B., & Padrik, P. (2020) · medRxiv · doi:10.1101/2020.08.17.20176263 · Cited by 3
Design and quality control of large-scale two-sample Mendelian randomisation studiesPreprint
Haycock, P., Borges, M. C., Burrows, K., Lemaître, R. N., Harrison, S., Burgess, S., Chang, X., Westra, J., Khankari, N. K., Tsilidis, K. K., et al. (2021) · medRxiv · doi:10.1101/2021.07.30.21260578 · Cited by 3
Self-citationNovel discoveries and enhanced genomic prediction from modelling genetic risk of cancer age-at-onsetPreprint
Maksimova, E. S., Ojavee, S. E., Läll, K., Sadler, M. C., Mägi, R., Kutalik, Z., & Robinson, M. R. (2022) · medRxiv · doi:10.1101/2022.03.25.22272955 · Cited by 3
“We were able to use studies with around 80,000 prostate 439 cancer cases [11], 120,000 breast cancer cases [9].”
BackgroundMethodPublicly Available Privacy-preserving Benchmarks for Polygenic PredictionPreprint
Witteveen, M. J., Pedersen, E. M., Meijsen, J. J., Andersen, M. R., Privé, F., Speed, D., & Vilhjálmsson, B. J. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.10.10.510645 · Cited by 2
Mitchell, J., Camacho, N., Shea, P., Stopsack, K. H., Vijai, J., Burren, O. S., Dhindsa, R. S., Nag, A., Berchuck, J. E., O’Neill, A., et al. (2024) · medRxiv · doi:10.1101/2024.05.10.24307164 · Cited by 3
Self-citationScreening for Prostate Cancer with a Polygenic Risk Score
Eklund, M., Thompson, I. M., & Cooperberg, M. R. (2025) · New England Journal of Medicine · doi:10.1056/nejmc2507786 · Cited by 3
Self-citationYang, F., Guo, P., Wang, K., Zhang, X., Hu, Z., Lou, Q., Ge, Q., Chen, Y., Liang, C. Y., & Meng, J. (2024) · Prostate International · doi:10.1016/j.prnil.2024.07.003 · Cited by 2
“For prostate cancer, we obtained GWAS data from the Prostate Cancer Association Group to Investigate Cancer Associated Alterations in the Genome consortium 14 with a sample size of 140,254 individuals.”
Liu, X., Duan, H., Liu, S., Zhang, Y., Ji, Y., Zhang, Y., Feng, Z., Li, J., Liu, Y., Gao, Y., et al. (2024) · Frontiers in Genetics · doi:10.3389/fgene.2024.1387588 · Cited by 2
Guo, J., Huang, T., & Zhou, H. (2025) · Discover Oncology · doi:10.1007/s12672-025-02172-4 · Cited by 2
“The study ultimately identified 62 novel loci significantly associated with PCa (P < 5 × 10 ⁻ 8 ), as well as one locus significantly associated with early-onset PCa [16].”
Review of Mendelian randomization studies on common male-specific diseases
Pang, Q., Chang, Z., Liu, H., Chen, J., Ma, S., Zhang, C., & Sun, Z.-X. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1541744 · Cited by 2
Self-citation
Metadata
- Authors
- Study, T. P., Schumacher, F. R., (APCB), A. P. C. B., Study, T. I., Canary PASS Investigators, Breast and Prostate Cancer Cohort Consortium (BPC3), The PRACTICAL (Prostate Cancer Association Group to Investigate Cancer-Associated Alterations in the Genome) Consortium, (CAPS), C. O. T. P. I. S., Prostate Cancer Genome-wide Association Study of Uncommon Susceptibility Loci (PEGASUS), The Genetic Associations and Mechanisms in Oncology (GAME-ON)/Elucidating Loci Involved in Prostate Cancer Susceptibility (ELLIPSE) Consortium, Al Olama, A. A., Berndt, S. I., Benlloch, S., Ahmed, M., Saunders, E. J., Dadaev, T., Leongamornlert, D., Anokian, E., Cieza-Borrella, C., Goh, C., Brook, M. N., Sheng, X., Fachal, L., Dennis, J., Tyrer, J., Muir, K., Lophatananon, A., Stevens, V. L., Gapstur, S. M., Carter, B. D., Tangen, C. M., Goodman, P. J., Thompson, I. M., Batra, J., Chambers, S., Moya, L., Clements, J., Horvath, L., Tilley, W., Risbridger, G. P., Gronberg, H., Aly, M., Nordström, T., Pharoah, P., Pashayan, N., Schleutker, J., Tammela, T. L. J., Sipeky, C., Auvinen, A., Albanes, D., Weinstein, S., Wolk, A., Håkansson, N., West, C. M. L., Dunning, A. M., Burnet, N., Mucci, L. A., Giovannucci, E., Andriole, G. L., Cussenot, O., Cancel-Tassin, G., Koutros, S., Beane Freeman, L. E., Sorensen, K. D., Orntoft, T. F., Borre, M., Maehle, L., Grindedal, E. M., Neal, D. E., Donovan, J. L., Hamdy, F. C., Martin, R. M., Travis, R. C., Key, T. J., Hamilton, R. J., Fleshner, N. E., Finelli, A., Ingles, S. A., Stern, M. C., Rosenstein, B. S., Kerns, S. L., Ostrer, H., Lu, Y.-J., Zhang, H.-W., Feng, N., Mao, X., Guo, X., Wang, G., Sun, Z., Giles, G. G., Southey, M. C., MacInnis, R. J., FitzGerald, L. M., Kibel, A. S., Drake, B. F., Vega, A., Gómez-Caamaño, A., Szulkin, R., Eklund, M., Kogevinas, M., Llorca, J., Castaño-Vinyals, G., Penney, K. L., Stampfer, M., Park, J. Y., Sellers, T. A., Lin, H.-Y., Stanford, J. L., Cybulski, C., Wokolorczyk, D., Lubinski, J., Ostrander, E. A., Geybels, M. S., Nordestgaard, B. G., Nielsen, S. F., Weischer, M., Bisbjerg, R., Røder, M. A., Iversen, P., Brenner, H., Cuk, K., Holleczek, B., Maier, C., Luedeke, M., Schnoeller, T., Kim, J., Logothetis, C. J., John, E. M., Teixeira, M. R., Paulo, P., Cardoso, M., Neuhausen, S. L., Steele, L., Ding, Y. C., De Ruyck, K., De Meerleer, G., Ost, P., Razack, A., Lim, J., Teo, S.-H., Lin, D. W., Newcomb, L. F., Lessel, D., Gamulin, M., Kulis, T., Kaneva, R., Usmani, N., Singhal, S., Slavov, C., Mitev, V., Parliament, M., Claessens, F., Joniau, S., Van den Broeck, T., Larkin, S., Townsend, P. A., Aukim-Hastie, C., Gago-Dominguez, M., Castelao, J. E., Martinez, M. E., Roobol, M. J., Jenster, G., van Schaik, R. H. N., Menegaux, F., Truong, T., Koudou, Y. A., Xu, J., Khaw, K.-T., Cannon-Albright, L., Pandha, H., Michael, A., Thibodeau, S. N., McDonnell, S. K., Schaid, D. J., Lindstrom, S., Turman, C., Ma, J., Hunter, D. J., Riboli, E., Siddiq, A., Canzian, F., Kolonel, L. N., Le Marchand, L., Hoover, R. N., Machiela, M. J., Cui, Z., Kraft, P., Amos, C. I., Conti, D. V., Easton, D. F., Wiklund, F., Chanock, S. J., Henderson, B. E., Kote-Jarai, Z., Haiman, C. A., & Eeles, R. A.
- Affiliations
- Case Western Reserve University (US)
- University of Cambridge (GB)
- Division of Cancer Epidemiology and Genetics (US)
- Institute of Cancer Research (GB)
- University of Manchester (GB)
- American Cancer Society (US)
- Griffith University (AU)
- Translational Research Institute (AU)
- Garvan Institute of Medical Research (AU)
- Karolinska University Hospital (SE)
- University of Turku (FI)
- Tampere University (FI)
- Karolinska Institutet (SE)
- Uppsala University (SE)
- Harvard University (US)
- Washington University in St. Louis (US)
- Aarhus University Hospital (DK)
- Oslo University Hospital (NO)
- Aarhus University (DK)
- Princess Margaret Cancer Centre (CA)
- University of Oxford (GB)
- Albert Einstein College of Medicine (US)
- Queen Mary University of London (GB)
- Second Military Medical University (CN)
- Nanjing Medical University (CN)
- Shanghai Medical College of Fudan University (CN)
- Cancer Council Victoria (AU)
- Brigham and Women's Hospital (US)
- The University of Melbourne (AU)
- Monash Health (AU)
- University of Tasmania (AU)
- Universitat Pompeu Fabra (ES)
- Fundación Pública Galega de Medicina Xenómica (ES)
- Universidad de Cantabria (ES)
- Moffitt Cancer Center (US)
- National Institutes of Health (US)
- University of Washington (US)
- University of Copenhagen (DK)
- Copenhagen University Hospital (DK)
- German Cancer Research Center (DE)
- Herlev Hospital (DK)
- The University of Texas MD Anderson Cancer Center (US)
- Cancer Prevention Institute of California (US)
- Universidade do Porto (PT)
- Instituto Português de Oncologia Francisco Gentil (PT)
- Ghent University (BE)
- Ghent University Hospital (BE)
- University of Malaya (MY)
- University Hospital Centre Zagreb (HR)
- University of Alberta (CA)
- Alexandrovska Hospital (BG)
- Southampton General Hospital (GB)
- University of Surrey (GB)
- Universitair Ziekenhuis Leuven (BE)
- Manchester Academic Health Science Centre (GB)
- Inserm (FR)
- Endeavor Health (US)
- Mayo Clinic (US)
- USC Norris Comprehensive Cancer Center (US)
- Dartmouth College (US)
- Royal Marsden NHS Foundation Trust (GB)
- Corresponding author
- Schumacher, Fredrick R.
- Eeles, Rosalind A.
- ORCID
- Schumacher, Fredrick R.
- Berndt, Sonja I.
- Ahmed, Mahbubl
- Saunders, Edward J.
- Dadaev, Tokhir
- Leongamornlert, Daniel
- Anokian, Ezequiel
- Cieza-Borrella, Clara
- Goh, Chee
- Brook, Mark N.
- Sheng, Xin
- Fachal, Laura
- Dennis, Joe
- Tyrer, Jonathan
- Muir, Kenneth
- Lophatananon, Artitaya
- Stevens, Victoria L.
- Gapstur, Susan M.
- Carter, Brian D.
- Tangen, Catherine M.
- Goodman, Phyllis J.
- Thompson, Ian M.
- Batra, Jyotsna
- Chambers, Suzanne
- Moya, Leire
- Clements, Judith
- Horvath, Lisa
- Tilley, Wayne
- Risbridger, Gail P.
- Aly, Markus
- Nordström, Tobias
- Pharoah, Paul
- Pashayan, Nora
- Schleutker, Johanna
- Tammela, Teuvo L. J.
- Sipeky, Csilla
- Auvinen, Anssi
- Albanes, Demetrius
- Weinstein, Stephanie
- Wolk, Alicja
- Håkansson, Niclas
- West, Catharine M. L.
- Dunning, Alison M.
- Burnet, Neil
- Mucci, Lorelei A.
- Giovannucci, Edward
- Andriole, Gerald L.
- Cussenot, Olivier
- Koutros, Stella
- Borre, Michael
- Grindedal, Eli Marie
- Neal, David E.
- Donovan, Jenny L.
- Hamdy, Freddie C.
- Martin, Richard M.
- Travis, Ruth C.
- Hamilton, Robert J.
- Fleshner, Neil E.
- Finelli, Antonio
- Ingles, Sue Ann
- Stern, Mariana C.
- Rosenstein, Barry S.
- Kerns, Sarah L.
- Lu, Yong-Jie
- Zhang, Hong-Wei
- Feng, Ninghan
- Mao, Xueying
- Wang, Guomin
- Giles, Graham G.
- Southey, Melissa C.
- MacInnis, Robert J.
- FitzGerald, Liesel M.
- Kibel, Adam S.
- Drake, Bettina F.
- Vega, Ana
- Szulkin, Robert
- Eklund, Martin
- Kogevinas, Manolis
- Llorca, Javier
- Penney, Kathryn L.
- Stampfer, Meir
- Park, Jong Y.
- Sellers, Thomas A.
- Lin, Hui-Yi
- Stanford, Janet L.
- Cybulski, Cezary
- Ostrander, Elaine A.
- Nordestgaard, Børge G.
- Nielsen, Sune F.
- Weischer, Maren
- Bisbjerg, Rasmus
- Røder, Martin Andreas
- Iversen, Peter
- Brenner, Hermann
- Holleczek, Bernd
- Kim, Jeri
- Logothetis, Christopher J.
- John, Esther M.
- Teixeira, Manuel R.
- Paulo, Paula
- Cardoso, Marta
- Neuhausen, Susan L.
- Steele, Linda
- Ding, Yuan Chun
- Ost, Piet
- Razack, Azad
- Lim, Jasmine
- Teo, Soo-Hwang
- Lin, Daniel W.
- Lessel, Davor
- Gamulin, Marija
- Kaneva, Radka
- Usmani, Nawaid
- Singhal, Sandeep
- Slavov, Chavdar
- Mitev, Vanio
- Parliament, Matthew
- Claessens, Frank
- Joniau, Steven
- Townsend, Paul A.
- Castelao, Jose Esteban
- Roobol, Monique J.
- Jenster, Guido
- van Schaik, Ron H. N.
- Truong, Thérèse
- Xu, Jianfeng
- Khaw, Kay-Tee
- Pandha, Hardev
- Michael, Agnieszka
- Thibodeau, Stephen N.
- McDonnell, Shannon K.
- Schaid, Daniel J.
- Turman, Constance
- Ma, Jing
- Siddiq, Afshan
- Canzian, Federico
- Kolonel, Laurence N.
- Hoover, Robert N.
- Machiela, Mitchell J.
- Cui, Zuxi
- Kraft, Peter
- Amos, Christopher I.
- Conti, David V.
- Easton, Douglas F.
- Wiklund, Fredrik
- Chanock, Stephen J.
- Haiman, Christopher A.
- Eeles, Rosalind A.
- Venue
- Nature Genetics
- Published
- 2018-06-11
- Volume
- 50
- Issue
- 7
- Pages
- 928-936
- ISSN
- 1061-4036 (ISSN-L)
- 1546-1718
- PMC
- PMC6568012
- OpenAlex
- W2806504012
- Cited by
- 902
- References
- 65
- Citations by year
- 2026: 53 · 2025: 96 · 2024: 133 · 2023: 123 · 2022: 151 · 2021: 132 · 2020: 104 · 2019: 79 · 2018: 30
- FWCI
- 52.93
- Type
- journal article
- Language
- en
- Update notices
- correction (2019-01-08)
- Open access
- bronze
- doi.org
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Genetics (publishedVersion)
- Research at the University of Copenhagen (University of Copenhagen) (publishedVersion, other-oa)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- St George's Online Research Archive (St George's University of London) (acceptedVersion)
- QUT ePrints (Queensland University of Technology) (submittedVersion)
- Surrey Research Insight Open Access (The University of Surrey) (submittedVersion)
- Civil War Book Review (submittedVersion)
- eCite Digital Repository (University of Tasmania) (submittedVersion)
- UTAS Research Repository (submittedVersion)
- EUR Research Repository (Erasmus University Rotterdam) (submittedVersion)
- HAL (submittedVersion, other-oa)
- Ghent University Academic Bibliography (Ghent University) (submittedVersion)
- Adelaide Research & Scholarship (AR&S) (University of Adelaide) (submittedVersion)
- ePrints Soton (University of Southampton) (submittedVersion)
- UCL Discovery (University College London) (submittedVersion)
- eScholarship (California Digital Library) (submittedVersion)
- Figshare (submittedVersion)
- Lirias (submittedVersion)
- UTS ePRESS (University of Technology Sydney) (submittedVersion)
- Research Explorer (The University of Manchester) (submittedVersion)
- Bristol Research (University of Bristol) (submittedVersion, other-oa)
- Griffith Research Online (submittedVersion)
- Spiral (Imperial College London) (submittedVersion)
- Apollo (University of Cambridge) (submittedVersion)
- Apollo
- Funders
- U.S. Department of Defense (C5047/A10692, C1287/A10118, C5047/A7357, W81XWH, C1287/A16563, C8197/A16565, C1281/A12014, C5047/A8384, C12292/A11174, C5047/A15007, CA128978, W81XWH1010341, 223175)
- Cancer Research Institute
- Prostate Cancer Foundation
- Breast Cancer Research Foundation (C5047/A10692, C5047/A15007, C1287/A10118, CA128978, 209057, C1287/A16563, W81XWH-10-1-0341, C8197/A16565, C5047/A8384, C1281/A12014, 396414, C12292/A11174, HEALTH-F2-2009-223175)
- Ovarian Cancer Research Fund (W81XWH-10-1-0341, C1281/A12014, C1287/A10118, C8197/A16565, C12292/A11174, CA128978, C5047/A10692, C5047/A15007, C1287/A16563, C5047/A8384, HEALTH-F2-2009-223175)
- University of Southern California (C1281/A12014, C5047/A10692, C8197/A16565, C1287/A10118, C12292/A11174, C5047/A8384, W81XWH-10-1-0341, C5047/A15007, CA128978, C1287/A16563, HEALTH-F2-2009-223175)
- Aarhus Universitet
- Aarhus Universitetshospital
- Case Western Reserve University
- Harvard T.H. Chan School of Public Health
- Institut for Klinisk Medicin, Aarhus Universitet
- National Cancer Research Institute
- Royal Marsden NHS Foundation Trust
- Australian Prostate Cancer Research
- Cancer Research UK (C8197/A16565’, 223175, C1281/A12014, 10119, C5047/A7357, C5047/A15007’, C1287‐A10118, 12014, HEALTHF2-2009-223175, C5047/A3354, 21332, 16561, 16565, C12292/A11174, ‘C5047/A10692, 15007, C1287, C5047/A8384, 10118, 14136, 16563, 18504, 16491, 17528, C16913-A6135, CA128978, A16563, 19169, C1287-A10710, W81XWH-10-1-0341, C1287‐A16563, C1281)
- National Institute for Health and Care Research (C5047/A15007, W81XWH-10-1-0341, NF-SI-0510-10096, C8197/A16565, HEALTH-F2-2009-223175, NF-SI-0509-10242, CA128978, C1287/A10118, C1281/A12014, NF-SI-0512-10114, C5047/A10692, NF-SI-0513-10121, C1287/A16563, C12292/A11174, C5047/A8384)
- University of Cambridge
- University of Warwick
- University College London
- University of Oxford
- European Commission (C1287/A10118, W81XWH-10-1-0341, C1281/A12014, C1287/A16563, C5047/A10692, C5047/A8384, C12292/A11174, C5047/A15007, C8197/A16565, CA128978, 223175)
- University of Bristol
- Prostate Cancer Foundation of Australia
- Monash University
- Griffith University
- Queensland University of Technology
- Cambridge University Hospitals
- Karolinska Institutet (W81XWH-10-1-0341, C1281/A12014, C1287/A10118, HEALTH-F2-2009-223175, C1287/A16563, CA128978, C5047/A8384, C5047/A10692, C12292/A11174, C8197/A16565, C5047/A15007)
- Peter MacCallum Cancer Centre
- Tampereen Yliopisto
- Turun Yliopisto
- Uppsala Universitet
- Tays
- Turun Yliopistollinen Keskussairaala
- National Institutes of Health (C1281/A12014, 223175, W81XWH-10-1-0341, C8197/A16565, C5047/A7357, C12292/A11174, C1287/A16563, W81XWH, C1287/A10118, HHSN268201200008I, C5047/A10692, HEALTH-F2-2009-223175, C5047/A15007, C5047/A8384, X01HG007492)
- Canadian Institutes of Health Research (C5047/A8384, C5047/A15007, C5047/A10692, C1287/A10118, C1287/A16563, CA128978, C8197/A16565, C1281/A12014, C12292/A11174, W81XWH-10-1-0341, HEALTH-F2-2009-223175, 223175)
- Medical Research Council (C12292/A11174, C1281/A12014, CA128978, C5047/A8384, HEALTH-F2-2009-223175, C8197/A16565, W81XWH-10-1-0341, C1287/A16563, C5047/A10692, MR/N003284/1, C1287/A10118, C5047/A15007)
- National Health and Medical Research Council (623204, 504702, 126402, 614296, 251533, 504700, 504715)
- Cancer Council Victoria (C1287/A16563, C1287/A10118, C8197/A16565, HEALTH-F2-2009-223175, C1281/A12014, C5047/A15007, C12292/A11174, W81XWH-10-1-0341, CA128978, C5047/A10692, C5047/A8384)
- Cancer Council Queensland
- Warwick Medical School
- Servicio Gallego de Salud
- Monash Biomedicine Discovery Institute, Monash University
- National Heart, Lung, and Blood Institute (HHSN268201200008I, HHSN268201200008C)
- National Cancer Institute (R01CA128978, U01CA188392, C5047/A15007, C5047/A10692, C5047/A8384, U19CA148065, HEALTH-F2-2009-223175, W81XWH-10-1-0341, UM1CA182883, UG1CA189974, U01CA098710, U19CA148537, K05CA175147, CA148065, U01CA098216, C1281/A12014, C12292/A11174, U01CA098758, U19CA148112, (CA128978, C1287/A16563, K07CA187546, C1287/A10118, C8197/A16565, U01CA098233, U10CA037429)
- Division of Cancer Epidemiology and Genetics, National Cancer Institute
- DOD Prostate Cancer Research Program
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Associations and Epidemiology
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Prostate Cancer Treatment and Research
- Health Sciences › Medicine › Urology › Prostate Cancer Diagnosis and Treatment
- Keywords
- prostate cancer, cancer susceptibility loci, genetic association, early-onset prostate cancer, polygenic risk score, ATM, p27, European ancestry, risk prediction, fine mapping
- MeSH terms
- Genotype, Humans, Male, Prostatic Neoplasms, Risk, Case-Control Studies, Genetic Predisposition to Disease, Polymorphism, Single Nucleotide, Genome-Wide Association Study, Genetic Loci
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
